Invention Grant
- Patent Title: Inhibiting chronic blood and nephrological disorders using lysine-based supplements
-
Application No.: US15870822Application Date: 2018-01-12
-
Publication No.: US10656166B2Publication Date: 2020-05-19
- Inventor: John Burd
- Applicant: Lysulin, Inc.
- Applicant Address: US CA San Diego
- Assignee: Lysulin, Inc.
- Current Assignee: Lysulin, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Sheppard Mullin Richter & Hampton LLP
- Main IPC: G01N33/70
- IPC: G01N33/70 ; A61K47/64 ; A23L33/15 ; G01N33/66 ; A23L33/16 ; A23L33/175 ; G01N33/68
Abstract:
A method of affecting blood chemistry using a supplement may comprise: measuring a blood glucose level; determining a blood glucose level; and if the blood glucose level exceeds a threshold, administering a supplement comprising lysine, zinc, and vitamin C.
Public/Granted literature
- US20190137519A1 INHIBITING CHRONIC BLOOD AND NEPHROLOGICAL DISORDERS USING LYSINE-BASED SUPPLEMENTS Public/Granted day:2019-05-09
Information query
IPC分类:
